{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:46:05Z","timestamp":1792201565838,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1245\/s10434-024-15316-7","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T16:10:41Z","timestamp":1714493441000},"page":"5370-5376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Value of Surgical Cytoreduction in Patients with Small Intestinal Neuroendocrine Tumors Metastatic to the Liver and Peritoneum"],"prefix":"10.1245","volume":"31","author":[{"given":"Hallbera","family":"Gudmundsdottir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Fogliati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis E.","family":"Grotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius A.","family":"Thiels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne G.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory L.","family":"Smoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Truty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Kendrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Nagorney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorvardur R.","family":"Halfdanarson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Starlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"key":"15316_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3:1335\u201342.","journal-title":"JAMA Oncol."},{"key":"15316_CR2","doi-asserted-by":"publisher","first-page":"100510","DOI":"10.1016\/j.lanepe.2022.100510","volume":"23","author":"BE White","year":"2022","unstructured":"White BE, Rous B, Chandrakumaran K, et al. Incidence and survival of neuroendocrine neoplasia in England 1995\u20132018: a retrospective, population-based study. Lancet Reg Health Eur. 2022;23:100510.","journal-title":"Lancet Reg Health Eur."},{"key":"15316_CR3","doi-asserted-by":"publisher","first-page":"e13264","DOI":"10.1111\/jne.13264","volume":"35","author":"E Thiis-Evensen","year":"2023","unstructured":"Thiis-Evensen E, Boyar Cetinkaya R. Incidence and prevalence of neuroendocrine neoplasms in Norway 1993\u20132021. J Neuroendocrinol. 2023;35:e13264.","journal-title":"J Neuroendocrinol."},{"key":"15316_CR4","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, et al. One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063\u201372.","journal-title":"J Clin Oncol."},{"key":"15316_CR5","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1002\/cam4.1507","volume":"7","author":"W Cai","year":"2018","unstructured":"Cai W, Tan Y, Ge W, Ding K, Hu H. Pattern and risk factors for distant metastases in gastrointestinal neuroendocrine neoplasms: a population-based study. Cancer Med. 2018;7:2699\u2013709.","journal-title":"Cancer Med."},{"key":"15316_CR6","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1002\/ijc.30400","volume":"139","author":"M Riihim\u00e4ki","year":"2016","unstructured":"Riihim\u00e4ki M, Hemminki A, Sundquist K, Sundquist J, Hemminki K. The epidemiology of metastases in neuroendocrine tumors. Int J Cancer. 2016;139:2679\u201386.","journal-title":"Int J Cancer."},{"key":"15316_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1072-7515(03)00230-8","volume":"197","author":"JM Sarmiento","year":"2003","unstructured":"Sarmiento JM, Heywood G, Rubin J, et al. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg. 2003;197:29\u201337.","journal-title":"J Am Coll Surg."},{"key":"15316_CR8","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1245\/s10434-011-1832-y","volume":"18","author":"SC Mayo","year":"2011","unstructured":"Mayo SC, de Jong MC, Bloomston M, et al. Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis. Ann Surg Oncol. 2011;18:3657\u201365.","journal-title":"Ann Surg Oncol."},{"key":"15316_CR9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1245\/ASO.2006.03.071","volume":"13","author":"DA Osborne","year":"2006","unstructured":"Osborne DA, Zervos EE, Strosberg J, et al. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors. Ann Surg Oncol. 2006;13:572\u201381.","journal-title":"Ann Surg Oncol."},{"key":"15316_CR10","doi-asserted-by":"publisher","first-page":"4840","DOI":"10.1245\/s10434-023-13372-z","volume":"30","author":"H Gudmundsdottir","year":"2023","unstructured":"Gudmundsdottir H, Habermann EB, Vierkant RA, et al. Survival and symptomatic relief after cytoreductive hepatectomy for neuroendocrine tumor liver metastases: long-term follow-up evaluation of more than 500 patients. Ann Surg Oncol. 2023;30:4840\u201351.","journal-title":"Ann Surg Oncol."},{"key":"15316_CR11","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1007\/s00268-020-05467-5","volume":"44","author":"P Addeo","year":"2020","unstructured":"Addeo P, Bertin JB, Imperiale A, et al. Outcomes of simultaneous resection of small bowel neuroendocrine tumors with synchronous liver metastases. World J Surg. 2020;44:2377\u201384.","journal-title":"World J Surg."},{"key":"15316_CR12","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s00268-011-1296-z","volume":"36","author":"O Norl\u00e9n","year":"2012","unstructured":"Norl\u00e9n O, St\u00e5lberg P, \u00d6berg K, et al. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center. World J Surg. 2012;36:1419\u201331.","journal-title":"World J Surg."},{"key":"15316_CR13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/PAS.0000000000001225","volume":"43","author":"MF Wright","year":"2019","unstructured":"Wright MF, Cates J, Gonzalez RS, Das S, Berlin JD, Shi C. Impact of peritoneal metastasis on survival of patients with small intestinal neuroendocrine tumor. Am J Surg Pathol. 2019;43:559\u201363.","journal-title":"Am J Surg Pathol."},{"key":"15316_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/MPA.0000000000000032","volume":"43","author":"F Panzuto","year":"2014","unstructured":"Panzuto F, Merola E, Rinzivillo M, et al. Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome. Pancreas. 2014;43:212\u20138.","journal-title":"Pancreas."},{"key":"15316_CR15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1159\/000503144","volume":"110","author":"E Merola","year":"2020","unstructured":"Merola E, Prasad V, Pascher A, et al. Peritoneal carcinomatosis in gastro-entero-pancreatic neuroendocrine neoplasms: clinical impact and effectiveness of the available therapeutic options. Neuroendocrinology. 2020;110:517\u201324.","journal-title":"Neuroendocrinology."},{"key":"15316_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1102\/1470-7330.2001.002","volume":"1","author":"JC Healy","year":"2001","unstructured":"Healy JC. Detection of peritoneal metastases. Cancer Imaging. 2001;1:4\u201312.","journal-title":"Cancer Imaging."},{"key":"15316_CR17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/MPA.0000000000000846","volume":"46","author":"JR Howe","year":"2017","unstructured":"Howe JR, Cardona K, Fraker DL, et al. The surgical management of small bowel neuroendocrine tumors: consensus guidelines of the North American neuroendocrine tumor society. Pancreas. 2017;46:715\u201331.","journal-title":"Pancreas"},{"key":"15316_CR18","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1007\/s11605-015-2895-z","volume":"19","author":"CR Shubert","year":"2015","unstructured":"Shubert CR, Habermann EB, Bergquist JR, et al. A NSQIP review of major morbidity and mortality of synchronous liver resection for colorectal metastasis stratified by extent of liver resection and type of colorectal resection. J Gastrointest Surg. 2015;19:1982\u201394.","journal-title":"J Gastrointest Surg."},{"key":"15316_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg."},{"key":"15316_CR20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ejso.2006.03.002","volume":"32","author":"FN Gilly","year":"2006","unstructured":"Gilly FN, Cotte E, Brigand C, et al. Quantitative prognostic indices in peritoneal carcinomatosis. Eur J Surg Oncol. 2006;32:597\u2013601.","journal-title":"Eur J Surg Oncol."},{"key":"15316_CR21","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1097\/SLA.0000000000004647","volume":"276","author":"S Bennett","year":"2022","unstructured":"Bennett S, Coburn N, Law C, et al. Upfront small bowel resection for small bowel neuroendocrine tumors with synchronous metastases: a propensity-score matched comparative population-based analysis. Ann Surg. 2022;276:e450\u20138.","journal-title":"Ann Surg."},{"key":"15316_CR22","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1677\/ERC-09-0042","volume":"16","author":"A Ahmed","year":"2009","unstructured":"Ahmed A, Turner G, King B, et al. Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study. Endocr Relat Cancer. 2009;16:885\u201394.","journal-title":"Endocr Relat Cancer."},{"key":"15316_CR23","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00268-002-6630-z","volume":"26","author":"P Hellman","year":"2002","unstructured":"Hellman P, Lundstr\u00f6m T, Ohrvall U, et al. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases. World J Surg. 2002;26:991\u20137.","journal-title":"World J Surg."},{"key":"15316_CR24","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1245\/s10434-012-2462-8","volume":"19","author":"S Gaujoux","year":"2012","unstructured":"Gaujoux S, Gonen M, Tang L, et al. Synchronous resection of primary and liver metastases for neuroendocrine tumors. Ann Surg Oncol. 2012;19:4270\u20137.","journal-title":"Ann Surg Oncol."},{"key":"15316_CR25","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1245\/s10434-018-6433-6","volume":"25","author":"DL Chan","year":"2018","unstructured":"Chan DL, Dixon M, Law CHL, et al. Outcomes of cytoreductive surgery for metastatic low-grade neuroendocrine tumors in the setting of extrahepatic metastases. Ann Surg Oncol. 2018;25:1768\u201374.","journal-title":"Ann Surg Oncol."},{"key":"15316_CR26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.surg.2020.03.030","volume":"169","author":"SM Wonn","year":"2021","unstructured":"Wonn SM, Limbach KE, Pommier SJ, et al. Outcomes of cytoreductive operations for peritoneal carcinomatosis with or without liver cytoreduction in patients with small bowel neuroendocrine tumors. Surgery. 2021;169:168\u201374.","journal-title":"Surgery."},{"key":"15316_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.surg.2013.05.030","volume":"155","author":"D Elias","year":"2014","unstructured":"Elias D, David A, Sourrouille I, et al. Neuroendocrine carcinomas: optimal surgery of peritoneal metastases (and associated intra-abdominal metastases). Surgery. 2014;155:5\u201312.","journal-title":"Surgery."},{"key":"15316_CR28","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.ejso.2022.03.019","volume":"48","author":"R Hajjar","year":"2022","unstructured":"Hajjar R, Mercier F, Passot G, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for small bowel neuroendocrine tumors with peritoneal metastasis. Eur J Surg Oncol. 2022;48:1626\u201330.","journal-title":"Eur J Surg Oncol."},{"key":"15316_CR29","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1002\/cncr.32865","volume":"126","author":"Chicago Consensus Working Group","year":"2020","unstructured":"Chicago Consensus Working Group. The Chicago consensus on peritoneal surface malignancies: management of neuroendocrine tumors. Cancer. 2020;126:2561\u20135.","journal-title":"Cancer."},{"key":"15316_CR30","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/jso.25811","volume":"121","author":"Y Kasai","year":"2020","unstructured":"Kasai Y, Hirose K, Corvera CU, et al. Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis. J Surg Oncol. 2020;121:330\u20136.","journal-title":"J Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15316-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15316-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15316-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T21:03:30Z","timestamp":1720645410000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15316-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["15316"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15316-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,30]]},"assertion":[{"value":"15 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Thorvardur R. Halfdanarson has undertaken consulting\/advisory board work for Ipsen, TerSera, ScioScientific, Curium, Advanced Accelerator Applications (a Novartis company), Terumo, ITM Isotopen Technologien Muenchen, and Crinetics. He has also received research support from Thermo Fisher Scientific, Advanced Accelerator Applications (a Novartis company), Basilea, Turnstone Biologics, and Agios. Hallbera Gudmundsdottir, Alessandro Fogliati, Travis E. Grotz, Cornelius A. Thiels, Susanne G. Warner, Rory L. Smoot, Mark J. Truty, Michael L. Kendrick, David M. Nagorney, Sean P. Cleary, and Patrick Starlinger have no relevant financial disclosures and declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}